UCLA Health System
Grant in 2025
Comprised of Ronald Reagan UCLA Medical Center, UCLA Medical Center, Santa Monica; Resnick Neuropsychiatric Hospital at UCLA, Mattel Children's Hospital UCLA, and the UCLA Medical Group with its wide-reaching system of primary-care and specialty-care offices throughout the region, UCLA Health System is among the most comprehensive and advanced healthcare systems in the world.
CareTaker Medical
Grant in 2024
CareTaker Medical develops wireless patient monitoring devices. Its flagship product, CareTaker, is a wearable system that measures continuous beat-by-beat blood pressure, heart rate, respiration rate, and other hemodynamic parameters using only a finger cuff. The device securely transmits data over cellular networks or Bluetooth to enable remote patient monitoring within hospitals and during transport.
Teal Health specializes in developing at-home cervical cancer screening devices, aiming to enhance convenience, privacy, and accessibility for women. Their FDA-approved platform includes a sampling device, virtual consultations with licensed providers, secure laboratory testing, an online results portal, and coordination of follow-up care.
Amissa Health
Grant in 2024
Amissa develops mobile and wearable application solutions aimed at alleviating the challenges of Alzheimer's care. The company’s technology empowers caregivers by allowing them to geo-fence and locate loved ones who may wander, remotely monitor their activity and health, and predict behaviors associated with Alzheimer's. In addition to these features, Amissa offers wearable biosensors integrated with a cloud-based data platform that collects biometric data on activity levels, sleep patterns, and physiological changes. This comprehensive approach not only aids caregivers in monitoring patients but also provides valuable insights for researchers seeking to understand disease progression, ultimately enhancing the quality of life for individuals with dementia and related disorders.
Lasarrus is a medical device company founded in 2013 and headquartered in Baltimore, Maryland. The company specializes in developing wearable devices aimed at enhancing the physical therapy experience for patients, particularly those with chronic obstructive pulmonary disease. Lasarrus's innovative device facilitates remote monitoring and telemedicine by capturing physiological and range-of-motion data from various points on the body. This technology provides patients with an affordable, comfortable, and non-invasive means to track their health routines and accelerate their recovery process.
Preeclampsia Foundation
Grant in 2024
Preeclampsia Foundation is a nonprofit that focuses on reducing maternal and infant illness and death due to preeclampsia.
Phenomix Sciences
Grant in 2024
Founded in 2017, Phenomix Sciences is a biotechnology company specializing in metabolomics and genomics. It develops precision medicine tools for chronic disease management, focusing on obesity. The company's AI-driven platform offers a novel blood test to classify patients' unique pathophysiological phenotypes, enabling personalized treatment with improved efficacy and fewer side effects.
Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior integrates wearable devices with machine learning algorithms to analyze real-time data from various physiological metrics, such as heart rate and skin temperature. The company’s platform, known as Recovery, employs this data to deliver timely interventions tailored to the needs of individuals in recovery. By utilizing a SaaS business model, Behaivior aims to democratize mental health recovery and support, assisting users in maintaining their wellness while enabling care providers to enhance their service delivery. Through its proactive approach, Behaivior seeks to improve mental health outcomes and reduce crisis events associated with addiction.
BetterAge is a company dedicated to enhancing the health and well-being of older adults through innovative technology solutions. Founded on the principle that all adults can age well regardless of their current circumstances, BetterAge has developed a digital platform designed exclusively for this demographic. The platform provides personalized, objective content tailored to the needs of older adults, offering education and information about disease risks and actionable insights to support informed decision-making. By fostering a network of experts in aging services, health, and technology, BetterAge aims to create thriving communities where older adults can lead active and healthy lives.
Soterya
Seed Round in 2023
On average, we spend a third of our lives in bed. Our self-positioning bed; the Korus™, combined with our AI-driven software, is designed to provide precise sleep therapies improving lifestyle and medical care that benefits sleep wellness and faster recovery at home.
Satio develops biotechnology platforms for patch-based blood collection from consumers, using dried blood spots and whole blood samples. The technology enables simple, low-cost, convenient, and painless collection and includes patch portfolios that support potential drug delivery. The company focuses on providing real-time diagnostic and therapeutic insights to global communities, helping individuals act on these insights with confidence.
PediaMetrix is a pediatric health technology company that develops AI-powered cranial measurement and monitoring tools to detect and manage head shape abnormalities in newborns. Its SoftSpot platform provides quantitative cranial measurements via a smartphone app, enabling at-home and in-office use, and offers data-driven guidance and repositioning instructions for parents. The system also gives pediatricians access to simplified analysis and data from the app to support clinical decisions, and is supported by FDA-cleared digital tools for pediatric head assessment. Founded in 2018, the company is based in Rockville, Maryland, and leverages computer vision and artificial intelligence to lower healthcare costs and improve outcomes in pediatric head care.
DiagMetrics is a company that specializes in mask-based diagnostic systems designed to detect respiratory diseases, including Covid-19. Their innovative technology allows for the retrofitting of existing masks to convert breath vapor into a fluid biosample, facilitating non-invasive testing. The system is equipped with Bluetooth capabilities, enabling users to receive test results directly on their smartphones. By providing accessible and efficient diagnostic solutions, DiagMetrics aims to democratize testing and enhance the early detection of respiratory illnesses.
Advent Therapeutics
Grant in 2023
Advent Therapeutics specializes in developing therapies for micro-orphan indications, focusing on unmet medical needs in neonatal and pediatric patient populations. Based in Lumberville, Pennsylvania.
Domus Diagnostics
Grant in 2023
Founded in 2021, Domus Diagnostics specializes in respiratory disease home testing services via its care diagnostics platform. The company offers affordable, user-friendly, and accurate testing kits designed to address infectious disease outbreaks promptly.
Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior integrates wearable devices with machine learning algorithms to analyze real-time data from various physiological metrics, such as heart rate and skin temperature. The company’s platform, known as Recovery, employs this data to deliver timely interventions tailored to the needs of individuals in recovery. By utilizing a SaaS business model, Behaivior aims to democratize mental health recovery and support, assisting users in maintaining their wellness while enabling care providers to enhance their service delivery. Through its proactive approach, Behaivior seeks to improve mental health outcomes and reduce crisis events associated with addiction.
BIOS Health is a pioneering company focused on developing neural digital therapies by harnessing data-driven insights from the human nervous system. Co-founded by researchers from Cambridge University, the firm aims to revolutionize precision medicine through the identification of neural biomarkers that link nerve activity to various medical conditions. BIOS's innovative approach holds promise for treating chronic diseases such as hypertension, diabetes, rheumatoid arthritis, and neurodegenerative disorders like Parkinson's and Alzheimer's. The company's expertise encompasses a diverse range of fields, including neuroscience, machine learning, software engineering, and biotechnology, allowing it to create advanced solutions for improving the quality of life for individuals suffering from these conditions. Additionally, BIOS is engaged in developing prosthetic connectors that standardize the interface between bionic devices and the body's nervous and soft-tissue systems, enabling enhanced control and feedback for patients with prosthetics.
Ria Health is an online platform that provides telehealth services aimed at helping individuals modify their relationship with alcohol. It offers personalized treatment plans that include medication-assisted options and behavioral therapies, all facilitated by licensed healthcare professionals. The platform emphasizes continuous monitoring to help users track their progress and maintain accountability. Ria Health also features a mobile app that provides access to educational materials, support groups, and communication with care teams. This comprehensive approach is designed to assist users in managing alcohol consumption and fostering healthier habits, ultimately addressing the challenges associated with alcohol use disorder.
OvaryIT is a telehealth service dedicated to providing women with accessible and safe contraceptive options. Utilizing advanced science and technology, the company enables its physicians to collaborate with users in developing personalized plans that address both hormonal and non-hormonal contraceptive needs. OvaryIT's proprietary platform enhances patient safety and aids healthcare providers in identifying suitable contraceptive matches, ultimately promoting adherence and enhancing the effectiveness of contraception for patients.
Whitman-Walker Health
Grant in 2022
Whitman-Walker Health provides health and wellness services. They provide HIV, prep, pep, medical and community care, insurance navigation services, gender affirming care and services, youth and family support, legal services, dental health, and behavorial health services.
Coprata is a digital health and technology platform that offers innovative solutions for gut health monitoring through hands-free stool sampling and automated bowel movement analysis. By utilizing artificial intelligence and normal toilet usage, the company enables individuals to track their gut health and understand the impact of lifestyle choices, providing early warnings of potential health changes. Coprata's technology focuses on detecting and managing both acute and chronic gastrointestinal diseases while also offering insights into infectious diseases. With an emphasis on non-invasive methods, the platform allows for discreet health monitoring without significantly altering daily routines. The company aims to enhance personalized wellness and explores future applications in preventative health and remote patient monitoring.
PediaMetrix is a pediatric health technology company that develops AI-powered cranial measurement and monitoring tools to detect and manage head shape abnormalities in newborns. Its SoftSpot platform provides quantitative cranial measurements via a smartphone app, enabling at-home and in-office use, and offers data-driven guidance and repositioning instructions for parents. The system also gives pediatricians access to simplified analysis and data from the app to support clinical decisions, and is supported by FDA-cleared digital tools for pediatric head assessment. Founded in 2018, the company is based in Rockville, Maryland, and leverages computer vision and artificial intelligence to lower healthcare costs and improve outcomes in pediatric head care.
Enspectra Health
Grant in 2022
Enspectra Health, based in Mountain View, California, develops advanced imaging systems for medical research and diagnosis. Founded in 2012, the company has pioneered the world's first handheld multiphoton imager for human use, capable of visualizing beneath the skin in real-time. Its innovative system combines reflectance confocal and multiphoton laser scanning microscopy to generate multispectral images, enhancing dermatologists' ability to diagnose and treat skin conditions, particularly cancers. Enspectra Health delivers these imaging systems to researchers studying various tissues and has a track record of delivering such systems since its inception.
Epicore Biosystems
Series A in 2022
Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.
Bleep provides best new CPAP solution on the market. Not sleeping sucks. Not sleeping and spending a fortune on CPAP devices that leak, fall off or leave marks on your face sucks even worse. That’s why they invented the DreamPort Sleep Solution – the world’s first-ever mask less CPAP device. The result is the smallest, lightest, most ergonomically accommodating CPAP solution on the market – a device that fits comfortably and doesn’t restrict your movement – enabling patients to get a better night’s sleep. Their goal is simple – to make the best bleeping CPAP products on the planet. They won’t stop until every sleep apnea patient is sleeping like a baby.
Viora Health
Pre Seed Round in 2021
Viora Health is a health and wellness company focused on advancing health equity among diverse populations. It develops tech-enabled, human-centered programs that utilize social and behavioral engagement to enhance the capacity, satisfaction, outcomes, and revenue for healthcare providers. Viora Health's offerings are designed to improve adherence to diabetes prevention and support patients through online tools that track data and report progress to diabetes prevention programs, facilitating compliance with insurance requirements. Funded by reputable organizations such as the American Heart Association, the National Institutes of Health, Johnson and Johnson, and the National Science Foundation, Viora Health's initiatives have shown significant success, achieving a 75% satisfaction score and double retention rates, while also leading to improved patient outcomes such as reduced stress, increased social support, and better access to food.
Chosen Diagnostics
Grant in 2021
Chosen Diagnostics is a developer of innovative biomarker diagnostic kits designed to enhance healthcare delivery for neonates. The company's primary focus is on diagnosing a prevalent and life-threatening bowel disease in preterm infants. Its diagnostic kit provides more accurate results compared to existing options, facilitating earlier medical intervention. By enabling healthcare professionals to detect critical conditions sooner, Chosen Diagnostics aims to improve treatment outcomes for thousands of low birth weight preterm infants, ultimately contributing to better health and survival rates in this vulnerable population.
Soterya
Seed Round in 2021
On average, we spend a third of our lives in bed. Our self-positioning bed; the Korus™, combined with our AI-driven software, is designed to provide precise sleep therapies improving lifestyle and medical care that benefits sleep wellness and faster recovery at home.
Enspectra Health
Grant in 2021
Enspectra Health, based in Mountain View, California, develops advanced imaging systems for medical research and diagnosis. Founded in 2012, the company has pioneered the world's first handheld multiphoton imager for human use, capable of visualizing beneath the skin in real-time. Its innovative system combines reflectance confocal and multiphoton laser scanning microscopy to generate multispectral images, enhancing dermatologists' ability to diagnose and treat skin conditions, particularly cancers. Enspectra Health delivers these imaging systems to researchers studying various tissues and has a track record of delivering such systems since its inception.
Xtrava Health
Grant in 2021
Xtrava Health, established in 2014 and headquartered in Santa Clara, California, specializes in developing contactless bio-sensing technology for health and wellness applications. The company's flagship product, Butterfly, is a wearable child wellness monitor that automatically tracks vital signs, sleep patterns, feeding, diaper changes, and activities, providing parents with comprehensive insights. Xtrava Health also develops and commercializes simple, accurate, and affordable diagnostic products for both professional and at-home use, focusing on respiratory health, employee wellness, and baby monitoring.
Arcascope develops a health app that uses algorithms tracking circadian rhythms to provide personalized recommendations, helping users reset their internal clocks for improved sleep and overall wellbeing.
Lactiga is a biotherapeutics company focused on developing novel biologics derived from human milk to treat and prevent infections in patients with Primary Immunodeficiency Diseases. Its mission is to improve the quality of life for these patients by battling even the world's most dangerous pathogens.
Samay specializes in remote respiratory health management. It develops AI-enabled wearable devices that monitor pulmonary volumes, trapped air, heart rates, breathing sounds, and lung temperature. This enables users to analyze their respiratory data and helps prevent respiratory diseases.
Intake Health
Grant in 2019
Intake Health develops a non-invasive, continuous health monitoring device that attaches to toilets. It automatically tests urine from flush water to generate lab-quality results for various health and diet indicators. The company aims to predict health conditions and enable personalized prevention by combining AI with thousands of biomarkers collected over time.
Recovery Force
Grant in 2019
Founded in 2013, Recovery Force is a digital health company specializing in wearable medical technology. It manufactures and supplies healthcare apparel, including sleeves and shoes, designed to enhance circulation, reduce post-operative pain, and improve patient mobility.
Bruin Biometrics
Grant in 2018
Bruin Biometrics LLC is a medical device company focused on developing and manufacturing biometric sensor-based solutions for the early identification and monitoring of chronic and preventable conditions. Established in 2009 and headquartered in Los Angeles, California, with an additional office in Manchester, United Kingdom, the company exclusively licenses wireless health technologies from the UCLA Wireless Health Institute. Its primary product, the Provizio SEM Scanner, is a handheld wireless device designed for assessing the risk of pressure injuries and ulcers. Additionally, Bruin Biometrics offers the OrthoSonos, an acoustic emission-based monitor for evaluating joint health in both natural and artificial joints. The company aims to provide effective wound care and orthopedic solutions while delivering real-time data capture, analytics, and reporting to enhance healthcare outcomes.
Arcascope develops a health app that uses algorithms tracking circadian rhythms to provide personalized recommendations, helping users reset their internal clocks for improved sleep and overall wellbeing.
Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior integrates wearable devices with machine learning algorithms to analyze real-time data from various physiological metrics, such as heart rate and skin temperature. The company’s platform, known as Recovery, employs this data to deliver timely interventions tailored to the needs of individuals in recovery. By utilizing a SaaS business model, Behaivior aims to democratize mental health recovery and support, assisting users in maintaining their wellness while enabling care providers to enhance their service delivery. Through its proactive approach, Behaivior seeks to improve mental health outcomes and reduce crisis events associated with addiction.
HealthRhythms
Grant in 2017
HealthRhythms develops a digital platform that assesses and monitors mental health conditions using deep machine learning and predictive analytics. Its solution offers real-time behavioral monitoring and personalized interventions, enabling healthcare providers to accurately measure mental health status and deliver timely care.
Wearable sensors are transforming healthcare by empowering health researchers, care providers, and patients with new insights.Together with their clinical research and enterprise partners, They develop innovative, market driven, wearable sensor solutions that address some of healthcare’s biggest challenges.
Accure Health
Grant in 2017
Accure Health is a privately held precision medicine company that develops AI-powered solutions to tailor therapies to individual patients based on biomarker profiles. The company aims to deliver targeted treatments to the right cells by combining proprietary protein design pipelines with a patented biomarker device, enabling biomarker-guided care and precision therapies.
Health Behavior Solutions
Grant in 2017
Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments.
Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching.
We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.
Health Behavior Solutions
Grant in 2017
Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments.
Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching.
We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.
Ossium Health
Grant in 2016
Ossium Health, Inc. is a biotechnology company that specializes in developing and manufacturing advanced cell therapy products aimed at treating blood cancers, improving organ transplantation, and repairing tissue damage caused by radiation exposure. Established in 2016 and based in San Francisco, the company has created a range of therapies, including HPC, Marrow, which consists of human leukocyte antigen (HLA)-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients. Additionally, Ossium offers Chimera, designed to enhance organ transplantation, and Chymalis, which utilizes mesenchymal stem cells from bone marrow to facilitate the healing of damaged bone and muscle tissue. The company also supplies bone marrow cells for research in oncology, immunology, and related fields, focusing on improving health and longevity through innovative bioengineering techniques.
Founded in 2006, 23andMe is a biotechnology company specializing in direct-to-consumer genetic testing. It offers DNA analysis services through home-based saliva collection kits, providing insights into ancestry, traits, and health risks.
Health Behavior Solutions
Grant in 2016
Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments.
Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching.
We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.
Coriell Institute for Medical Research
Grant in 2016
Coriell Institute for Medical Research, founded in 1953 and based in Camden, New Jersey, is an independent non-profit research center dedicated to the study of the human genome. Expert staff and pioneering programs in the fields of personalized medicine, cell biology, cytogenetics, genotyping, and biobanking drive Their mission.
The emerging field of personalized medicine draws upon a person’s genomic information to tailor treatments and prescription drug dosing to optimize health outcomes. The Coriell Personalized Medicine Collaborative (CPMC) research study is seeking to understand the usefulness of genetic risk and pharmacogenomics in clinical decision-making and healthcare management.
Health Behavior Solutions
Grant in 2016
Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments.
Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching.
We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.
Founded in 1863, Mayo Clinic is a non-profit organization based in Minnesota, United States. It provides comprehensive medical care services across various specialties, conducts extensive research, and offers education in clinical medicine.
SpeechVive Inc. is a medical device company developing a wearable speech device to assist people with Parkinson's disease by improving speech and communication. Founded in 2011 and based in Lafayette, Indiana, the company aims to enhance speech volume and clarity for daily life. The device is designed to suppress ambient background sound, which helps users hear themselves more clearly and speak more effectively, addressing communication challenges associated with Parkinson's disease.
Daktari Diagnostics
Grant in 2015
Daktari Diagnostics, Inc. is a healthcare solutions company based in Cambridge, Massachusetts, focused on developing portable point-of-care diagnostic platforms to enhance disease management globally. Founded in 2008, the company offers several innovative products, including Daktari Virology for the detection of Hepatitis C and HIV, Daktari InSight, a cloud-based data management service, and Daktari Sickle Cell, which identifies infants with sickle cell disease from a single drop of blood. Daktari’s technology is designed specifically for resource-poor markets, featuring built-in wireless connectivity that facilitates real-time data sharing among healthcare providers. By delivering critical diagnostic information efficiently, Daktari aims to improve clinical outcomes and support global health initiatives. The company's commitment to affordability and quality ensures that its products are accessible to healthcare professionals and patients worldwide.
Founded in 1863, Mayo Clinic is a non-profit organization based in Minnesota, United States. It provides comprehensive medical care services across various specialties, conducts extensive research, and offers education in clinical medicine.
Insightfil improves patient medication management by offering a unique Personalized Wellness Portfolio (PWP), which dispenses custom medication regimens. This platform connects patients, clinics, and pill manufacturers to enhance adherence, reduce errors, optimize healthcare professional time, and minimize waste.
Founded in 2006, 23andMe is a biotechnology company specializing in direct-to-consumer genetic testing. It offers DNA analysis services through home-based saliva collection kits, providing insights into ancestry, traits, and health risks.
Daktari Diagnostics
Grant in 2014
Daktari Diagnostics, Inc. is a healthcare solutions company based in Cambridge, Massachusetts, focused on developing portable point-of-care diagnostic platforms to enhance disease management globally. Founded in 2008, the company offers several innovative products, including Daktari Virology for the detection of Hepatitis C and HIV, Daktari InSight, a cloud-based data management service, and Daktari Sickle Cell, which identifies infants with sickle cell disease from a single drop of blood. Daktari’s technology is designed specifically for resource-poor markets, featuring built-in wireless connectivity that facilitates real-time data sharing among healthcare providers. By delivering critical diagnostic information efficiently, Daktari aims to improve clinical outcomes and support global health initiatives. The company's commitment to affordability and quality ensures that its products are accessible to healthcare professionals and patients worldwide.
Xhale is a company based in Gainesville, Florida, founded in 2005, that specializes in developing advanced patient monitoring technologies. The company is known for its innovative SMART medication adherence monitoring technology and a propofol monitor, both aimed at enhancing patient care in clinical settings. Xhale's devices are designed to improve conventional pulse oximetry by enabling the monitoring of critical patient parameters through a simple, effective single-point-of-contact sensor. In 2010, Xhale successfully commercialized its HyGreen hand hygiene monitoring system, which later became a separate entity with its own management team. The company's focus on expanding the capabilities of patient monitoring is intended to improve health outcomes in hospitals and other clinical environments.
Insightfil improves patient medication management by offering a unique Personalized Wellness Portfolio (PWP), which dispenses custom medication regimens. This platform connects patients, clinics, and pill manufacturers to enhance adherence, reduce errors, optimize healthcare professional time, and minimize waste.
Noom, Inc. is a New York-based company that specializes in mobile health coaching through a psychology-based digital health platform. Founded in 2008, Noom develops a mobile application that combines evidence-based curricula, personalized coaching, and data-driven insights to help users achieve their health and wellness goals, including weight management and chronic disease prevention. The platform offers scalable tools for exercise and nutrition coaching, utilizing artificial intelligence to facilitate behavioral change. Recognized for its innovative approach, Noom has received multiple grants from the National Institutes of Health and was the first mobile application certified by the Centers for Disease Control as a diabetes prevention program. The company also caters to business enterprises, supporting organizations in promoting employee health. With additional offices in Seoul and Tokyo, Noom continues to expand its global reach and impact on personal health management.
Insightfil improves patient medication management by offering a unique Personalized Wellness Portfolio (PWP), which dispenses custom medication regimens. This platform connects patients, clinics, and pill manufacturers to enhance adherence, reduce errors, optimize healthcare professional time, and minimize waste.
Insightfil improves patient medication management by offering a unique Personalized Wellness Portfolio (PWP), which dispenses custom medication regimens. This platform connects patients, clinics, and pill manufacturers to enhance adherence, reduce errors, optimize healthcare professional time, and minimize waste.
Viora Health is a health and wellness company focused on advancing health equity among diverse populations. It develops tech-enabled, human-centered programs that utilize social and behavioral engagement to enhance the capacity, satisfaction, outcomes, and revenue for healthcare providers. Viora Health's offerings are designed to improve adherence to diabetes prevention and support patients through online tools that track data and report progress to diabetes prevention programs, facilitating compliance with insurance requirements. Funded by reputable organizations such as the American Heart Association, the National Institutes of Health, Johnson and Johnson, and the National Science Foundation, Viora Health's initiatives have shown significant success, achieving a 75% satisfaction score and double retention rates, while also leading to improved patient outcomes such as reduced stress, increased social support, and better access to food.